Northern America: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Northern America

In 2021, the North American medicaments containing insulin market was finally on the rise to reach $X for the first time since 2017, thus ending a three-year declining trend. Over the period under review, consumption, however, continues to indicate a deep reduction. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Northern America

In value terms, medicaments containing insulin production expanded to $X in 2021 estimated in export price. Overall, production, however, recorded a drastic downturn. The level of production peaked at $X in 2012; however, from 2013 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Northern America

In 2021, after three years of growth, there was significant decline in shipments abroad of medicaments containing insulin but not antibiotics, when their volume decreased by -41.2% to X tons. In general, exports, however, posted a resilient expansion. The most prominent rate of growth was recorded in 2019 with an increase of 100% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2020, and then dropped dramatically in the following year.

In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Over the period under review, exports saw a drastic downturn. The growth pace was the most rapid in 2018 with an increase of 81% against the previous year. The level of export peaked at $X in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

Exports by Country

The biggest shipments were from the United States (X tons), together accounting for 99.9% of total export.

The United States was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +13.1% from 2012 to 2021. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) also remains the largest medicaments containing insulin supplier in Northern America.

From 2012 to 2021, the average annual growth rate of value in the United States amounted to -6.6%.

Export Prices by Country

The export price in Northern America stood at $X per ton in 2021, shrinking by -4.2% against the previous year. Over the period under review, the export price faced a deep downturn. The pace of growth was the most pronounced in 2016 an increase of 10% against the previous year. Over the period under review, the export prices reached the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to -17.4% per year.

Medicaments Containing Insulin Imports

Imports in Northern America

In 2021, the amount of medicaments containing insulin but not antibiotics imported in Northern America contracted sharply to X tons, declining by -22.1% on the previous year. Over the period under review, imports recorded a deep contraction. The most prominent rate of growth was recorded in 2019 with an increase of 5,104% against the previous year. Over the period under review, imports hit record highs at X tons in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports dropped dramatically to $X in 2021. Overall, imports recorded a sharp decrease. The most prominent rate of growth was recorded in 2019 with an increase of 843% against the previous year. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.

Imports by Country

Canada dominates imports structure, amounting to X tons, which was near 97% of total imports in 2021. The United States (X kg) followed a long way behind the leaders.

Canada was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of -5.0% from 2012 to 2021. The United States (-32.5%) illustrated a downward trend over the same period. From 2012 to 2021, the share of Canada increased by +35 percentage points.

In value terms, Canada ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Northern America, comprising 76% of total imports. The second position in the ranking was taken by the United States ($X), with a 22% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of value in Canada totaled -7.4%.

Import Prices by Country

In 2021, the import price in Northern America amounted to $X per ton, growing by 6.1% against the previous year. In general, the import price, however, showed a dramatic shrinkage. The growth pace was the most rapid in 2018 an increase of 449% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was the United States ($X per ton), while Canada amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Canada (-2.5%).

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :